A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis
Work
Year: 2021
Type: article
Abstract: Systemic atopic dermatitis treatments that have acceptable safety are needed.To evaluate the safety of the oral Janus kinase inhibitor upadacitinib in combination with topical corticosteroids (TCSs) f... more
Source: JAAD International
Institutions Kyoto Prefectural University of Medicine, National Center For Child Health and Development, Nagasaki University, Okayama University, Fukuyama City Hospital +4 more
Cites: 23
Cited by: 45
Related to: 10
FWCI: 9.5
Citation percentile (by year/subfield): 89.7
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,500